Results 21 to 30 of about 1,726 (212)

Skin phototype of participants in laser and light treatments of cosmetic dermatologic conditions: A systematic review

Journal of Cosmetic Dermatology, Volume 22, Issue 9, Page 2434-2439, September 2023., 2023
Abstract Background In cosmetic dermatology, lasers and lights treat a variety of hair and skin conditions, including some that disproportionately affect people of color. Aims Our systematic review aims to understand the representation of participants with skin phototypes 4–6 in cosmetic dermatologic trials studying laser and light devices.
Priya Manjaly, Eric Xia, Alexandra Allan, Shreya Vinjamuri, Henriette De La Garza, Cyriac Manjaly, Mindy D. Szeto, Shaundra Eichstadt, Mayra Maymone, Neelam Vashi   +9 more
wiley   +1 more source

Risk of skin cancers in mycosis fungoides patients receiving PUVA therapy: A real‐life experience from a single tertiary center

Photodermatology, Photoimmunology &Photomedicine, Volume 39, Issue 5, Page 428-434, September 2023., 2023
Abstract Background Mycosis fungoides (MF) is the most common cutaneous T‐cell lymphoma. Skin‐directed therapies, including phototherapy, are the first‐line treatment modalities. Psoralen plus ultraviolet A light photochemotherapy (PUVA) is quite effective in controlling the disease; however, long‐term adverse effects, particularly carcinogenesis, are ...
Pelin Ertop Doğan, Bengü Nisa Akay, Seçil Vural, Canan Arı, Tuğçe Ertürk Yılmaz, Hatice Şanlı   +5 more
wiley   +1 more source

Immunogenic Cell Death in Hematological Malignancy Therapy

Advanced Science, Volume 10, Issue 13, May 5, 2023., 2023
This article introduces the concept of immunogenic death and current therapy can lead to immunogenic death in hematologic malignancy disease therapy, which will open up new ideas for the diseases treatment. Abstract Although the curative effect of hematological malignancies has been improved in recent years, relapse or drug resistance of hematological ...
Zhaoyun Liu, Xintong Xu, Kaining Liu, Jingtian Zhang, Dan Ding, Rong Fu   +5 more
wiley   +1 more source

Efficacy of ultraviolet A1 phototherapy for inflammatory, sclerotic and neoplastic dermatological diseases: A 10‐year tertiary referral center experience

Photodermatology, Photoimmunology &Photomedicine, Volume 39, Issue 3, Page 256-262, May 2023., 2023
Abstract Background Ultraviolet (UV) A1 phototherapy is considered a beneficial treatment for various inflammatory, sclerotic, malignant, and other skin conditions. However, the available data regarding its efficacy for different indications, the potential side effects, and the recommended treatment protocols are sparse.
Shachar Ronen, Yuval Ramot, Abraham Zlotogorski, Rony Shreberk‐Hassidim   +3 more
wiley   +1 more source

Cutaneous T‐cell lymphomas: 2023 update on diagnosis, risk‐stratification, and management

American Journal of Hematology, Volume 98, Issue 1, Page 193-209, January 2023., 2023
Abstract Disease Overview Cutaneous T‐cell lymphomas are a heterogenous group of T‐cell neoplasms involving the skin, the majority of which may be classified as Mycosis Fungoides (MF) or Sézary Syndrome (SS). Diagnosis The diagnosis of MF or SS requires the integration of clinical and histopathologic data.
Alexandra C. Hristov, Trilokraj Tejasvi, Ryan A. Wilcox   +2 more
wiley   +1 more source

Primary cutaneous lymphoma patients seen at a referral dermatological centre in 1 year: A single‐centre observational retrospective cohort study of the diagnoses and staging, comorbidities and associated symptoms, treatment performed and clinical course

Journal of the European Academy of Dermatology and Venereology, Volume 36, Issue 12, Page 2388-2392, December 2022., 2022
Abstract Importance Primary cutaneous lymphomas (PCL) are rare diseases, but the indolent course makes their prevalence high. Although there are many treatment options, no hierarchy is recommended. Objective To identify the burden of PCL and describe clinical‐pathologic features; associated comorbidities; analyse treatment approaches in real‐life and ...
N. Macagno, L. Mastorino, M. Rubatto, G. Avallone, M. Merli, A. Agostini, P. Fava, S. Ribero, P. Quaglino   +8 more
wiley   +1 more source

Outcome of extracorporeal photopheresis in mycosis fungoides patients is not predicted by quotients of systemic immune‐inflammatory biomarkers

Journal of Clinical Apheresis, Volume 37, Issue 4, Page 360-366, August 2022., 2022
Abstract Background Systemic immune‐inflammatory biomarkers (SIIBs) have not been studied in mycosis fungoides (MF) patients undergoing extracorporeal photopheresis (ECP). Objective The objective was to determine whether recently proposed SIIBs are suitable to predict ECP treatment outcome and overall prognosis of patients with MF.
Thilo Gambichler, Jan Späth, Shayda Said, Christina H. Scheel, Laura Susok, Rene Stranzenbach   +5 more
wiley   +1 more source

CLINICAL EFFICACY OF EXTRA-CORPOREAL PHOTOCHEMOTHERAPY IN SYSTEMIC LUPUS ERYTHEMATOSUS

Alʹmanah Kliničeskoj Mediciny, 2016
Aim: To assess clinical efficacy of extracorporeal photochemotherapy in patients with systemic lupus erythematosus (SLE). Materials and methods: 30 SLE patients were thoroughly examined.
A. V. Molochkov, A. V. Kil’dyushevskiy, O. V. Karzanov, L. S. Bagapsh   +3 more
doaj   +1 more source

Mechanisms of lymphocytotoxicity induced by extracorporeal photochemotherapy for cutaneous T cell lymphoma. [PDF]

J Clin Invest, 1990
Marks DI, Rockman SP, Oziemski MA, Fox RM.   +3 more
europepmc   +3 more sources

Extracorporeal photopheresis for systemic sclerosis: A meta‐analysis of randomized clinical trials

Dermatologic Therapy, Volume 35, Issue 7, July 2022., 2022
Abstract Systemic sclerosis (scleroderma) (SSc) is a rare autoimmune disorder characterized by excessive production of collagen. Extracorporeal photopheresis (photochemotherapy, phototherapy) (ECP) involves repeated exposure of peripheral blood lymphocytes to ultraviolet A (UVA) radiation. The rationale for treating patients with SSc by ECP lies in its
Claudia Delbrück, Thilo Gambichler, Laura Susok, Frank Peinemann   +3 more
wiley   +1 more source